Tanabe, N.; Saeki, I.; Aibe, Y.; Matsuda, T.; Hanazono, T.; Nishi, M.; Hidaka, I.; Kuwashiro, S.; Shiratsuki, S.; Matsuura, K.;
et al. Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers 2023, 15, 2927.
https://doi.org/10.3390/cancers15112927
AMA Style
Tanabe N, Saeki I, Aibe Y, Matsuda T, Hanazono T, Nishi M, Hidaka I, Kuwashiro S, Shiratsuki S, Matsuura K,
et al. Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers. 2023; 15(11):2927.
https://doi.org/10.3390/cancers15112927
Chicago/Turabian Style
Tanabe, Norikazu, Issei Saeki, Yuki Aibe, Takashi Matsuda, Tadasuke Hanazono, Maiko Nishi, Isao Hidaka, Shinya Kuwashiro, Shogo Shiratsuki, Keiji Matsuura,
and et al. 2023. "Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma" Cancers 15, no. 11: 2927.
https://doi.org/10.3390/cancers15112927
APA Style
Tanabe, N., Saeki, I., Aibe, Y., Matsuda, T., Hanazono, T., Nishi, M., Hidaka, I., Kuwashiro, S., Shiratsuki, S., Matsuura, K., Egusa, M., Nishiyama, N., Fujioka, T., Kawamoto, D., Sasaki, R., Nishimura, T., Oono, T., Hisanaga, T., Matsumoto, T.,
... Takami, T.
(2023). Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers, 15(11), 2927.
https://doi.org/10.3390/cancers15112927
